Global Biologics and Biosimilars Market Insights and Forecast to 2028

Report ID: 1200841 | Published Date: Jan 2025 | No. of Page: 114 | Base Year: 2024 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Biologics and Biosimilars Product Introduction
    1.2 Market by Type
        1.2.1 Global Biologics and Biosimilars Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Monoclonal Antibodies
        1.2.3 Interferon
        1.2.4 Erythropoietin
        1.2.5 Insulin
        1.2.6 Vaccines
        1.2.7 Others
    1.3 Market by Application
        1.3.1 Global Biologics and Biosimilars Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Tumor
        1.3.3 Diabetes
        1.3.4 Cardiovascular
        1.3.5 Hemophilia
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Biologics and Biosimilars Sales Estimates and Forecasts 2017-2028
    2.2 Global Biologics and Biosimilars Revenue Estimates and Forecasts 2017-2028
    2.3 Global Biologics and Biosimilars Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Biologics and Biosimilars Sales by Region
        2.4.1 Global Biologics and Biosimilars Sales by Region (2017-2022)
        2.4.2 Global Sales Biologics and Biosimilars by Region (2023-2028)
    2.5 Global Biologics and Biosimilars Revenue by Region
        2.5.1 Global Biologics and Biosimilars Revenue by Region (2017-2022)
        2.5.2 Global Biologics and Biosimilars Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Biologics and Biosimilars Sales by Manufacturers
        3.1.1 Global Top Biologics and Biosimilars Manufacturers by Sales (2017-2022)
        3.1.2 Global Biologics and Biosimilars Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Biologics and Biosimilars in 2021
    3.2 Global Biologics and Biosimilars Revenue by Manufacturers
        3.2.1 Global Biologics and Biosimilars Revenue by Manufacturers (2017-2022)
        3.2.2 Global Biologics and Biosimilars Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Biologics and Biosimilars Revenue in 2021
    3.3 Global Biologics and Biosimilars Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Biologics and Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Biologics and Biosimilars Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Biologics and Biosimilars Sales by Type
        4.1.1 Global Biologics and Biosimilars Historical Sales by Type (2017-2022)
        4.1.2 Global Biologics and Biosimilars Forecasted Sales by Type (2023-2028)
        4.1.3 Global Biologics and Biosimilars Sales Market Share by Type (2017-2028)
    4.2 Global Biologics and Biosimilars Revenue by Type
        4.2.1 Global Biologics and Biosimilars Historical Revenue by Type (2017-2022)
        4.2.2 Global Biologics and Biosimilars Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Biologics and Biosimilars Revenue Market Share by Type (2017-2028)
    4.3 Global Biologics and Biosimilars Price by Type
        4.3.1 Global Biologics and Biosimilars Price by Type (2017-2022)
        4.3.2 Global Biologics and Biosimilars Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Biologics and Biosimilars Sales by Application
        5.1.1 Global Biologics and Biosimilars Historical Sales by Application (2017-2022)
        5.1.2 Global Biologics and Biosimilars Forecasted Sales by Application (2023-2028)
        5.1.3 Global Biologics and Biosimilars Sales Market Share by Application (2017-2028)
    5.2 Global Biologics and Biosimilars Revenue by Application
        5.2.1 Global Biologics and Biosimilars Historical Revenue by Application (2017-2022)
        5.2.2 Global Biologics and Biosimilars Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Biologics and Biosimilars Revenue Market Share by Application (2017-2028)
    5.3 Global Biologics and Biosimilars Price by Application
        5.3.1 Global Biologics and Biosimilars Price by Application (2017-2022)
        5.3.2 Global Biologics and Biosimilars Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Biologics and Biosimilars Market Size by Type
        6.1.1 North America Biologics and Biosimilars Sales by Type (2017-2028)
        6.1.2 North America Biologics and Biosimilars Revenue by Type (2017-2028)
    6.2 North America Biologics and Biosimilars Market Size by Application
        6.2.1 North America Biologics and Biosimilars Sales by Application (2017-2028)
        6.2.2 North America Biologics and Biosimilars Revenue by Application (2017-2028)
    6.3 North America Biologics and Biosimilars Market Size by Country
        6.3.1 North America Biologics and Biosimilars Sales by Country (2017-2028)
        6.3.2 North America Biologics and Biosimilars Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Biologics and Biosimilars Market Size by Type
        7.1.1 Europe Biologics and Biosimilars Sales by Type (2017-2028)
        7.1.2 Europe Biologics and Biosimilars Revenue by Type (2017-2028)
    7.2 Europe Biologics and Biosimilars Market Size by Application
        7.2.1 Europe Biologics and Biosimilars Sales by Application (2017-2028)
        7.2.2 Europe Biologics and Biosimilars Revenue by Application (2017-2028)
    7.3 Europe Biologics and Biosimilars Market Size by Country
        7.3.1 Europe Biologics and Biosimilars Sales by Country (2017-2028)
        7.3.2 Europe Biologics and Biosimilars Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Biologics and Biosimilars Market Size by Type
        8.1.1 Asia Pacific Biologics and Biosimilars Sales by Type (2017-2028)
        8.1.2 Asia Pacific Biologics and Biosimilars Revenue by Type (2017-2028)
    8.2 Asia Pacific Biologics and Biosimilars Market Size by Application
        8.2.1 Asia Pacific Biologics and Biosimilars Sales by Application (2017-2028)
        8.2.2 Asia Pacific Biologics and Biosimilars Revenue by Application (2017-2028)
    8.3 Asia Pacific Biologics and Biosimilars Market Size by Region
        8.3.1 Asia Pacific Biologics and Biosimilars Sales by Region (2017-2028)
        8.3.2 Asia Pacific Biologics and Biosimilars Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Biologics and Biosimilars Market Size by Type
        9.1.1 Latin America Biologics and Biosimilars Sales by Type (2017-2028)
        9.1.2 Latin America Biologics and Biosimilars Revenue by Type (2017-2028)
    9.2 Latin America Biologics and Biosimilars Market Size by Application
        9.2.1 Latin America Biologics and Biosimilars Sales by Application (2017-2028)
        9.2.2 Latin America Biologics and Biosimilars Revenue by Application (2017-2028)
    9.3 Latin America Biologics and Biosimilars Market Size by Country
        9.3.1 Latin America Biologics and Biosimilars Sales by Country (2017-2028)
        9.3.2 Latin America Biologics and Biosimilars Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Biologics and Biosimilars Market Size by Type
        10.1.1 Middle East and Africa Biologics and Biosimilars Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Biologics and Biosimilars Revenue by Type (2017-2028)
    10.2 Middle East and Africa Biologics and Biosimilars Market Size by Application
        10.2.1 Middle East and Africa Biologics and Biosimilars Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Biologics and Biosimilars Revenue by Application (2017-2028)
    10.3 Middle East and Africa Biologics and Biosimilars Market Size by Country
        10.3.1 Middle East and Africa Biologics and Biosimilars Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Biologics and Biosimilars Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Roche
        11.1.1 Roche Corporation Information
        11.1.2 Roche Overview
        11.1.3 Roche Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Roche Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Roche Recent Developments
    11.2 Amgen
        11.2.1 Amgen Corporation Information
        11.2.2 Amgen Overview
        11.2.3 Amgen Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Amgen Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Amgen Recent Developments
    11.3 AbbVie
        11.3.1 AbbVie Corporation Information
        11.3.2 AbbVie Overview
        11.3.3 AbbVie Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 AbbVie Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 AbbVie Recent Developments
    11.4 Sanofi-Aventis
        11.4.1 Sanofi-Aventis Corporation Information
        11.4.2 Sanofi-Aventis Overview
        11.4.3 Sanofi-Aventis Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Sanofi-Aventis Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Sanofi-Aventis Recent Developments
    11.5 Johnson & Johnson
        11.5.1 Johnson & Johnson Corporation Information
        11.5.2 Johnson & Johnson Overview
        11.5.3 Johnson & Johnson Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Johnson & Johnson Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Johnson & Johnson Recent Developments
    11.6 Pfizer
        11.6.1 Pfizer Corporation Information
        11.6.2 Pfizer Overview
        11.6.3 Pfizer Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Pfizer Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Pfizer Recent Developments
    11.7 Novo Nordisk
        11.7.1 Novo Nordisk Corporation Information
        11.7.2 Novo Nordisk Overview
        11.7.3 Novo Nordisk Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Novo Nordisk Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Novo Nordisk Recent Developments
    11.8 Eli Lilly
        11.8.1 Eli Lilly Corporation Information
        11.8.2 Eli Lilly Overview
        11.8.3 Eli Lilly Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Eli Lilly Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Eli Lilly Recent Developments
    11.9 Novartis
        11.9.1 Novartis Corporation Information
        11.9.2 Novartis Overview
        11.9.3 Novartis Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Novartis Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Novartis Recent Developments
    11.10 Merck
        11.10.1 Merck Corporation Information
        11.10.2 Merck Overview
        11.10.3 Merck Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Merck Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Merck Recent Developments
    11.11 3sbio
        11.11.1 3sbio Corporation Information
        11.11.2 3sbio Overview
        11.11.3 3sbio Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 3sbio Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 3sbio Recent Developments
    11.12 Changchun High Tech
        11.12.1 Changchun High Tech Corporation Information
        11.12.2 Changchun High Tech Overview
        11.12.3 Changchun High Tech Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Changchun High Tech Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Changchun High Tech Recent Developments
    11.13 CP Guojian
        11.13.1 CP Guojian Corporation Information
        11.13.2 CP Guojian Overview
        11.13.3 CP Guojian Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 CP Guojian Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 CP Guojian Recent Developments
    11.14 Biotech
        11.14.1 Biotech Corporation Information
        11.14.2 Biotech Overview
        11.14.3 Biotech Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
        11.14.4 Biotech Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
        11.14.5 Biotech Recent Developments
    11.15 Gelgen
        11.15.1 Gelgen Corporation Information
        11.15.2 Gelgen Overview
        11.15.3 Gelgen Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
        11.15.4 Gelgen Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
        11.15.5 Gelgen Recent Developments
    11.16 Innovent
        11.16.1 Innovent Corporation Information
        11.16.2 Innovent Overview
        11.16.3 Innovent Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
        11.16.4 Innovent Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
        11.16.5 Innovent Recent Developments
    11.17 Dong Bao
        11.17.1 Dong Bao Corporation Information
        11.17.2 Dong Bao Overview
        11.17.3 Dong Bao Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
        11.17.4 Dong Bao Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
        11.17.5 Dong Bao Recent Developments
    11.18 Ganlee
        11.18.1 Ganlee Corporation Information
        11.18.2 Ganlee Overview
        11.18.3 Ganlee Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
        11.18.4 Ganlee Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
        11.18.5 Ganlee Recent Developments
    11.19 United Laboratories
        11.19.1 United Laboratories Corporation Information
        11.19.2 United Laboratories Overview
        11.19.3 United Laboratories Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
        11.19.4 United Laboratories Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
        11.19.5 United Laboratories Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Biologics and Biosimilars Industry Chain Analysis
    12.2 Biologics and Biosimilars Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Biologics and Biosimilars Production Mode & Process
    12.4 Biologics and Biosimilars Sales and Marketing
        12.4.1 Biologics and Biosimilars Sales Channels
        12.4.2 Biologics and Biosimilars Distributors
    12.5 Biologics and Biosimilars Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Biologics and Biosimilars Industry Trends
    13.2 Biologics and Biosimilars Market Drivers
    13.3 Biologics and Biosimilars Market Challenges
    13.4 Biologics and Biosimilars Market Restraints
14 Key Findings in The Global Biologics and Biosimilars Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Biologics and Biosimilars Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Monoclonal Antibodies
    Table 3. Major Manufacturers of Interferon
    Table 4. Major Manufacturers of Erythropoietin
    Table 5. Major Manufacturers of Insulin
    Table 6. Major Manufacturers of Vaccines
    Table 7. Major Manufacturers of Others
    Table 8. Global Biologics and Biosimilars Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 9. Global Biologics and Biosimilars Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 10. Global Biologics and Biosimilars Sales by Region (2017-2022) & (K Units)
    Table 11. Global Biologics and Biosimilars Sales Market Share by Region (2017-2022)
    Table 12. Global Biologics and Biosimilars Sales by Region (2023-2028) & (K Units)
    Table 13. Global Biologics and Biosimilars Sales Market Share by Region (2023-2028)
    Table 14. Global Biologics and Biosimilars Revenue by Region (2017-2022) & (US$ Million)
    Table 15. Global Biologics and Biosimilars Revenue Market Share by Region (2017-2022)
    Table 16. Global Biologics and Biosimilars Revenue by Region (2023-2028) & (US$ Million)
    Table 17. Global Biologics and Biosimilars Revenue Market Share by Region (2023-2028)
    Table 18. Global Biologics and Biosimilars Sales by Manufacturers (2017-2022) & (K Units)
    Table 19. Global Biologics and Biosimilars Sales Share by Manufacturers (2017-2022)
    Table 20. Global Biologics and Biosimilars Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 21. Global Biologics and Biosimilars Revenue Share by Manufacturers (2017-2022)
    Table 22. Biologics and Biosimilars Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 23. Global Biologics and Biosimilars Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 24. Global Biologics and Biosimilars by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics and Biosimilars as of 2021)
    Table 25. Biologics and Biosimilars Manufacturing Base Distribution and Headquarters
    Table 26. Manufacturers Biologics and Biosimilars Product Offered
    Table 27. Date of Manufacturers Enter into Biologics and Biosimilars Market
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Biologics and Biosimilars Sales by Type (2017-2022) & (K Units)
    Table 30. Global Biologics and Biosimilars Sales by Type (2023-2028) & (K Units)
    Table 31. Global Biologics and Biosimilars Sales Share by Type (2017-2022)
    Table 32. Global Biologics and Biosimilars Sales Share by Type (2023-2028)
    Table 33. Global Biologics and Biosimilars Revenue by Type (2017-2022) & (US$ Million)
    Table 34. Global Biologics and Biosimilars Revenue by Type (2023-2028) & (US$ Million)
    Table 35. Global Biologics and Biosimilars Revenue Share by Type (2017-2022)
    Table 36. Global Biologics and Biosimilars Revenue Share by Type (2023-2028)
    Table 37. Biologics and Biosimilars Price by Type (2017-2022) & (USD/Unit)
    Table 38. Global Biologics and Biosimilars Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 39. Global Biologics and Biosimilars Sales by Application (2017-2022) & (K Units)
    Table 40. Global Biologics and Biosimilars Sales by Application (2023-2028) & (K Units)
    Table 41. Global Biologics and Biosimilars Sales Share by Application (2017-2022)
    Table 42. Global Biologics and Biosimilars Sales Share by Application (2023-2028)
    Table 43. Global Biologics and Biosimilars Revenue by Application (2017-2022) & (US$ Million)
    Table 44. Global Biologics and Biosimilars Revenue by Application (2023-2028) & (US$ Million)
    Table 45. Global Biologics and Biosimilars Revenue Share by Application (2017-2022)
    Table 46. Global Biologics and Biosimilars Revenue Share by Application (2023-2028)
    Table 47. Biologics and Biosimilars Price by Application (2017-2022) & (USD/Unit)
    Table 48. Global Biologics and Biosimilars Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 49. North America Biologics and Biosimilars Sales by Type (2017-2022) & (K Units)
    Table 50. North America Biologics and Biosimilars Sales by Type (2023-2028) & (K Units)
    Table 51. North America Biologics and Biosimilars Revenue by Type (2017-2022) & (US$ Million)
    Table 52. North America Biologics and Biosimilars Revenue by Type (2023-2028) & (US$ Million)
    Table 53. North America Biologics and Biosimilars Sales by Application (2017-2022) & (K Units)
    Table 54. North America Biologics and Biosimilars Sales by Application (2023-2028) & (K Units)
    Table 55. North America Biologics and Biosimilars Revenue by Application (2017-2022) & (US$ Million)
    Table 56. North America Biologics and Biosimilars Revenue by Application (2023-2028) & (US$ Million)
    Table 57. North America Biologics and Biosimilars Sales by Country (2017-2022) & (K Units)
    Table 58. North America Biologics and Biosimilars Sales by Country (2023-2028) & (K Units)
    Table 59. North America Biologics and Biosimilars Revenue by Country (2017-2022) & (US$ Million)
    Table 60. North America Biologics and Biosimilars Revenue by Country (2023-2028) & (US$ Million)
    Table 61. Europe Biologics and Biosimilars Sales by Type (2017-2022) & (K Units)
    Table 62. Europe Biologics and Biosimilars Sales by Type (2023-2028) & (K Units)
    Table 63. Europe Biologics and Biosimilars Revenue by Type (2017-2022) & (US$ Million)
    Table 64. Europe Biologics and Biosimilars Revenue by Type (2023-2028) & (US$ Million)
    Table 65. Europe Biologics and Biosimilars Sales by Application (2017-2022) & (K Units)
    Table 66. Europe Biologics and Biosimilars Sales by Application (2023-2028) & (K Units)
    Table 67. Europe Biologics and Biosimilars Revenue by Application (2017-2022) & (US$ Million)
    Table 68. Europe Biologics and Biosimilars Revenue by Application (2023-2028) & (US$ Million)
    Table 69. Europe Biologics and Biosimilars Sales by Country (2017-2022) & (K Units)
    Table 70. Europe Biologics and Biosimilars Sales by Country (2023-2028) & (K Units)
    Table 71. Europe Biologics and Biosimilars Revenue by Country (2017-2022) & (US$ Million)
    Table 72. Europe Biologics and Biosimilars Revenue by Country (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Biologics and Biosimilars Sales by Type (2017-2022) & (K Units)
    Table 74. Asia Pacific Biologics and Biosimilars Sales by Type (2023-2028) & (K Units)
    Table 75. Asia Pacific Biologics and Biosimilars Revenue by Type (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Biologics and Biosimilars Revenue by Type (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Biologics and Biosimilars Sales by Application (2017-2022) & (K Units)
    Table 78. Asia Pacific Biologics and Biosimilars Sales by Application (2023-2028) & (K Units)
    Table 79. Asia Pacific Biologics and Biosimilars Revenue by Application (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Biologics and Biosimilars Revenue by Application (2023-2028) & (US$ Million)
    Table 81. Asia Pacific Biologics and Biosimilars Sales by Region (2017-2022) & (K Units)
    Table 82. Asia Pacific Biologics and Biosimilars Sales by Region (2023-2028) & (K Units)
    Table 83. Asia Pacific Biologics and Biosimilars Revenue by Region (2017-2022) & (US$ Million)
    Table 84. Asia Pacific Biologics and Biosimilars Revenue by Region (2023-2028) & (US$ Million)
    Table 85. Latin America Biologics and Biosimilars Sales by Type (2017-2022) & (K Units)
    Table 86. Latin America Biologics and Biosimilars Sales by Type (2023-2028) & (K Units)
    Table 87. Latin America Biologics and Biosimilars Revenue by Type (2017-2022) & (US$ Million)
    Table 88. Latin America Biologics and Biosimilars Revenue by Type (2023-2028) & (US$ Million)
    Table 89. Latin America Biologics and Biosimilars Sales by Application (2017-2022) & (K Units)
    Table 90. Latin America Biologics and Biosimilars Sales by Application (2023-2028) & (K Units)
    Table 91. Latin America Biologics and Biosimilars Revenue by Application (2017-2022) & (US$ Million)
    Table 92. Latin America Biologics and Biosimilars Revenue by Application (2023-2028) & (US$ Million)
    Table 93. Latin America Biologics and Biosimilars Sales by Country (2017-2022) & (K Units)
    Table 94. Latin America Biologics and Biosimilars Sales by Country (2023-2028) & (K Units)
    Table 95. Latin America Biologics and Biosimilars Revenue by Country (2017-2022) & (US$ Million)
    Table 96. Latin America Biologics and Biosimilars Revenue by Country (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Biologics and Biosimilars Sales by Type (2017-2022) & (K Units)
    Table 98. Middle East and Africa Biologics and Biosimilars Sales by Type (2023-2028) & (K Units)
    Table 99. Middle East and Africa Biologics and Biosimilars Revenue by Type (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Biologics and Biosimilars Revenue by Type (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Biologics and Biosimilars Sales by Application (2017-2022) & (K Units)
    Table 102. Middle East and Africa Biologics and Biosimilars Sales by Application (2023-2028) & (K Units)
    Table 103. Middle East and Africa Biologics and Biosimilars Revenue by Application (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Biologics and Biosimilars Revenue by Application (2023-2028) & (US$ Million)
    Table 105. Middle East and Africa Biologics and Biosimilars Sales by Country (2017-2022) & (K Units)
    Table 106. Middle East and Africa Biologics and Biosimilars Sales by Country (2023-2028) & (K Units)
    Table 107. Middle East and Africa Biologics and Biosimilars Revenue by Country (2017-2022) & (US$ Million)
    Table 108. Middle East and Africa Biologics and Biosimilars Revenue by Country (2023-2028) & (US$ Million)
    Table 109. Roche Corporation Information
    Table 110. Roche Description and Major Businesses
    Table 111. Roche Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 112. Roche Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
    Table 113. Roche Recent Developments
    Table 114. Amgen Corporation Information
    Table 115. Amgen Description and Major Businesses
    Table 116. Amgen Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 117. Amgen Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
    Table 118. Amgen Recent Developments
    Table 119. AbbVie Corporation Information
    Table 120. AbbVie Description and Major Businesses
    Table 121. AbbVie Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 122. AbbVie Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
    Table 123. AbbVie Recent Developments
    Table 124. Sanofi-Aventis Corporation Information
    Table 125. Sanofi-Aventis Description and Major Businesses
    Table 126. Sanofi-Aventis Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 127. Sanofi-Aventis Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
    Table 128. Sanofi-Aventis Recent Developments
    Table 129. Johnson & Johnson Corporation Information
    Table 130. Johnson & Johnson Description and Major Businesses
    Table 131. Johnson & Johnson Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 132. Johnson & Johnson Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
    Table 133. Johnson & Johnson Recent Developments
    Table 134. Pfizer Corporation Information
    Table 135. Pfizer Description and Major Businesses
    Table 136. Pfizer Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 137. Pfizer Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
    Table 138. Pfizer Recent Developments
    Table 139. Novo Nordisk Corporation Information
    Table 140. Novo Nordisk Description and Major Businesses
    Table 141. Novo Nordisk Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 142. Novo Nordisk Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
    Table 143. Novo Nordisk Recent Developments
    Table 144. Eli Lilly Corporation Information
    Table 145. Eli Lilly Description and Major Businesses
    Table 146. Eli Lilly Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 147. Eli Lilly Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
    Table 148. Eli Lilly Recent Developments
    Table 149. Novartis Corporation Information
    Table 150. Novartis Description and Major Businesses
    Table 151. Novartis Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 152. Novartis Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
    Table 153. Novartis Recent Developments
    Table 154. Merck Corporation Information
    Table 155. Merck Description and Major Businesses
    Table 156. Merck Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 157. Merck Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
    Table 158. Merck Recent Developments
    Table 159. 3sbio Corporation Information
    Table 160. 3sbio Description and Major Businesses
    Table 161. 3sbio Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 162. 3sbio Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
    Table 163. 3sbio Recent Developments
    Table 164. Changchun High Tech Corporation Information
    Table 165. Changchun High Tech Description and Major Businesses
    Table 166. Changchun High Tech Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 167. Changchun High Tech Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
    Table 168. Changchun High Tech Recent Developments
    Table 169. CP Guojian Corporation Information
    Table 170. CP Guojian Description and Major Businesses
    Table 171. CP Guojian Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 172. CP Guojian Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
    Table 173. CP Guojian Recent Developments
    Table 174. Biotech Corporation Information
    Table 175. Biotech Description and Major Businesses
    Table 176. Biotech Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 177. Biotech Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
    Table 178. Biotech Recent Developments
    Table 179. Gelgen Corporation Information
    Table 180. Gelgen Description and Major Businesses
    Table 181. Gelgen Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 182. Gelgen Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
    Table 183. Gelgen Recent Developments
    Table 184. Innovent Corporation Information
    Table 185. Innovent Description and Major Businesses
    Table 186. Innovent Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 187. Innovent Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
    Table 188. Innovent Recent Developments
    Table 189. Dong Bao Corporation Information
    Table 190. Dong Bao Description and Major Businesses
    Table 191. Dong Bao Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 192. Dong Bao Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
    Table 193. Dong Bao Recent Developments
    Table 194. Ganlee Corporation Information
    Table 195. Ganlee Description and Major Businesses
    Table 196. Ganlee Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 197. Ganlee Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
    Table 198. Ganlee Recent Developments
    Table 199. United Laboratories Corporation Information
    Table 200. United Laboratories Description and Major Businesses
    Table 201. United Laboratories Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 202. United Laboratories Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
    Table 203. United Laboratories Recent Developments
    Table 204. Key Raw Materials Lists
    Table 205. Raw Materials Key Suppliers Lists
    Table 206. Biologics and Biosimilars Distributors List
    Table 207. Biologics and Biosimilars Customers List
    Table 208. Biologics and Biosimilars Market Trends
    Table 209. Biologics and Biosimilars Market Drivers
    Table 210. Biologics and Biosimilars Market Challenges
    Table 211. Biologics and Biosimilars Market Restraints
    Table 212. Research Programs/Design for This Report
    Table 213. Key Data Information from Secondary Sources
    Table 214. Key Data Information from Primary Sources
List of Figures
    Figure 1. Biologics and Biosimilars Product Picture
    Figure 3. Global Biologics and Biosimilars Market Share by Type in 2021 & 2028
    Figure 3. Monoclonal Antibodies Product Picture
    Figure 4. Interferon Product Picture
    Figure 5. Erythropoietin Product Picture
    Figure 6. Insulin Product Picture
    Figure 7. Vaccines Product Picture
    Figure 8. Others Product Picture
    Figure 9. Global Biologics and Biosimilars Market Share by Application in 2021 & 2028
    Figure 10. Tumor
    Figure 11. Diabetes
    Figure 12. Cardiovascular
    Figure 13. Hemophilia
    Figure 14. Others
    Figure 15. Biologics and Biosimilars Report Years Considered
    Figure 16. Global Biologics and Biosimilars Sales 2017-2028 (K Units)
    Figure 17. Global Biologics and Biosimilars Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 18. Global Biologics and Biosimilars Revenue 2017-2028 (US$ Million)
    Figure 19. Global Biologics and Biosimilars Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 20. Global Biologics and Biosimilars Sales Market Share by Region (2017-2022)
    Figure 21. Global Biologics and Biosimilars Sales Market Share by Region (2023-2028)
    Figure 22. North America Biologics and Biosimilars Sales YoY (2017-2028) & (K Units)
    Figure 23. North America Biologics and Biosimilars Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Europe Biologics and Biosimilars Sales YoY (2017-2028) & (K Units)
    Figure 25. Europe Biologics and Biosimilars Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Asia-Pacific Biologics and Biosimilars Sales YoY (2017-2028) & (K Units)
    Figure 27. Asia-Pacific Biologics and Biosimilars Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. Latin America Biologics and Biosimilars Sales YoY (2017-2028) & (K Units)
    Figure 29. Latin America Biologics and Biosimilars Revenue YoY (2017-2028) & (US$ Million)
    Figure 30. Middle East & Africa Biologics and Biosimilars Sales YoY (2017-2028) & (K Units)
    Figure 31. Middle East & Africa Biologics and Biosimilars Revenue YoY (2017-2028) & (US$ Million)
    Figure 32. The Biologics and Biosimilars Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 33. The Top 5 and 10 Largest Manufacturers of Biologics and Biosimilars in the World: Market Share by Biologics and Biosimilars Revenue in 2021
    Figure 34. Global Biologics and Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 35. Global Biologics and Biosimilars Sales Market Share by Type (2017-2028)
    Figure 36. Global Biologics and Biosimilars Revenue Market Share by Type (2017-2028)
    Figure 37. Global Biologics and Biosimilars Sales Market Share by Application (2017-2028)
    Figure 38. Global Biologics and Biosimilars Revenue Market Share by Application (2017-2028)
    Figure 39. North America Biologics and Biosimilars Sales Market Share by Type (2017-2028)
    Figure 40. North America Biologics and Biosimilars Revenue Market Share by Type (2017-2028)
    Figure 41. North America Biologics and Biosimilars Sales Market Share by Application (2017-2028)
    Figure 42. North America Biologics and Biosimilars Revenue Market Share by Application (2017-2028)
    Figure 43. North America Biologics and Biosimilars Sales Share by Country (2017-2028)
    Figure 44. North America Biologics and Biosimilars Revenue Share by Country (2017-2028)
    Figure 45. U.S. Biologics and Biosimilars Revenue (2017-2028) & (US$ Million)
    Figure 46. Canada Biologics and Biosimilars Revenue (2017-2028) & (US$ Million)
    Figure 47. Europe Biologics and Biosimilars Sales Market Share by Type (2017-2028)
    Figure 48. Europe Biologics and Biosimilars Revenue Market Share by Type (2017-2028)
    Figure 49. Europe Biologics and Biosimilars Sales Market Share by Application (2017-2028)
    Figure 50. Europe Biologics and Biosimilars Revenue Market Share by Application (2017-2028)
    Figure 51. Europe Biologics and Biosimilars Sales Share by Country (2017-2028)
    Figure 52. Europe Biologics and Biosimilars Revenue Share by Country (2017-2028)
    Figure 53. Germany Biologics and Biosimilars Revenue (2017-2028) & (US$ Million)
    Figure 54. France Biologics and Biosimilars Revenue (2017-2028) & (US$ Million)
    Figure 55. U.K. Biologics and Biosimilars Revenue (2017-2028) & (US$ Million)
    Figure 56. Italy Biologics and Biosimilars Revenue (2017-2028) & (US$ Million)
    Figure 57. Russia Biologics and Biosimilars Revenue (2017-2028) & (US$ Million)
    Figure 58. Asia Pacific Biologics and Biosimilars Sales Market Share by Type (2017-2028)
    Figure 59. Asia Pacific Biologics and Biosimilars Revenue Market Share by Type (2017-2028)
    Figure 60. Asia Pacific Biologics and Biosimilars Sales Market Share by Application (2017-2028)
    Figure 61. Asia Pacific Biologics and Biosimilars Revenue Market Share by Application (2017-2028)
    Figure 62. Asia Pacific Biologics and Biosimilars Sales Share by Region (2017-2028)
    Figure 63. Asia Pacific Biologics and Biosimilars Revenue Share by Region (2017-2028)
    Figure 64. China Biologics and Biosimilars Revenue (2017-2028) & (US$ Million)
    Figure 65. Japan Biologics and Biosimilars Revenue (2017-2028) & (US$ Million)
    Figure 66. South Korea Biologics and Biosimilars Revenue (2017-2028) & (US$ Million)
    Figure 67. India Biologics and Biosimilars Revenue (2017-2028) & (US$ Million)
    Figure 68. Australia Biologics and Biosimilars Revenue (2017-2028) & (US$ Million)
    Figure 69. Taiwan Biologics and Biosimilars Revenue (2017-2028) & (US$ Million)
    Figure 70. Indonesia Biologics and Biosimilars Revenue (2017-2028) & (US$ Million)
    Figure 71. Thailand Biologics and Biosimilars Revenue (2017-2028) & (US$ Million)
    Figure 72. Malaysia Biologics and Biosimilars Revenue (2017-2028) & (US$ Million)
    Figure 73. Philippines Biologics and Biosimilars Revenue (2017-2028) & (US$ Million)
    Figure 74. Latin America Biologics and Biosimilars Sales Market Share by Type (2017-2028)
    Figure 75. Latin America Biologics and Biosimilars Revenue Market Share by Type (2017-2028)
    Figure 76. Latin America Biologics and Biosimilars Sales Market Share by Application (2017-2028)
    Figure 77. Latin America Biologics and Biosimilars Revenue Market Share by Application (2017-2028)
    Figure 78. Latin America Biologics and Biosimilars Sales Share by Country (2017-2028)
    Figure 79. Latin America Biologics and Biosimilars Revenue Share by Country (2017-2028)
    Figure 80. Mexico Biologics and Biosimilars Revenue (2017-2028) & (US$ Million)
    Figure 81. Brazil Biologics and Biosimilars Revenue (2017-2028) & (US$ Million)
    Figure 82. Argentina Biologics and Biosimilars Revenue (2017-2028) & (US$ Million)
    Figure 83. Middle East and Africa Biologics and Biosimilars Sales Market Share by Type (2017-2028)
    Figure 84. Middle East and Africa Biologics and Biosimilars Revenue Market Share by Type (2017-2028)
    Figure 85. Middle East and Africa Biologics and Biosimilars Sales Market Share by Application (2017-2028)
    Figure 86. Middle East and Africa Biologics and Biosimilars Revenue Market Share by Application (2017-2028)
    Figure 87. Middle East and Africa Biologics and Biosimilars Sales Share by Country (2017-2028)
    Figure 88. Middle East and Africa Biologics and Biosimilars Revenue Share by Country (2017-2028)
    Figure 89. Turkey Biologics and Biosimilars Revenue (2017-2028) & (US$ Million)
    Figure 90. Saudi Arabia Biologics and Biosimilars Revenue (2017-2028) & (US$ Million)
    Figure 91. U.A.E Biologics and Biosimilars Revenue (2017-2028) & (US$ Million)
    Figure 92. Biologics and Biosimilars Value Chain
    Figure 93. Biologics and Biosimilars Production Process
    Figure 94. Channels of Distribution
    Figure 95. Distributors Profiles
    Figure 96. Bottom-up and Top-down Approaches for This Report
    Figure 97. Data Triangulation
    Figure 98. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
3sbio
Changchun High Tech
CP Guojian
Biotech
Gelgen
Innovent
Dong Bao
Ganlee
United Laboratories
Frequently Asked Questions
Biologics and Biosimilars report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Biologics and Biosimilars report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Biologics and Biosimilars report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports